薬物動態学および実験的治療学のジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Impact of Pain Pill on Antiplatelet Effects of Oral P2Y12 Receptor Inhibitors

Slobby RL

Morphine and P2Y12 receptor inhibitors square measure each suggested in patients with acute myocardial infarct. pain pill could impede epithelial duct absorption of many oral medication including P2Y12 blood platelet receptor inhibitors.The aim of this review was to critically discuss drug–drug interactions between oral P2Y12 receptor inhibitors and pain pill per presently offered data supported the findings of experimental, data-based and randomised clinical studies. pain pill is glucuronidated and sulfated at positions three and 6; the plasma concentration ratios correlate positively with birth weight, that in all probability reflects raised liver weight with increasing birth weight. Moreover, pain pill clearance correlates absolutely with age and birth weight. Steady-state pain pill plasma concentrations square measure achieved when 24-48 hours of infusion, however the glucuronide substance plasma concentrations don't reach steady state before sixty hours. The morphine-3-glucuronide substance has lower clearance, a shorter half-life and a smaller distribution volume compared with the morphine-6 substance, that is that the most active morphine-like agonist. Standard doses cause constipation, retentiveness and metastasis depression [1].